By Drug Target Review2025-12-05T08:30:36
Researchers in Japan have identified a promising blood-based marker that could enable faster, simpler and more accurate detection of liver fibrosis.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2023-01-20T14:24:55
Sponsored by Leica Microsystems
2023-04-12T15:15:18
Sponsored by Cellistic
2023-01-16T10:21:42
Sponsored by Sartorius Incucyte® Live-Cell Analysis System
2025-10-08T14:00:00
Sponsored by Eurofins Discovery
2024-02-07T14:34:33
Sponsored by BellBrook Labs
Site powered by Webvision Cloud